Suppr超能文献

一项为期10年的项目中糖尿病透析患者的发病率和死亡率:联合治疗的价值

[Morbidity and mortality of diabetic patients on dialysis in a 10-year program: value of combined treatment].

作者信息

Coronel F, Hortal L, Horcajo P, Naranjo P, del Pozo C, Torrente J, Barrientos A

出版信息

Med Clin (Barc). 1989 Jan 14;92(1):10-4.

PMID:2716373
Abstract

Morbidity and mortality derived from the employed techniques after ten year experience in treating patients afflicted with end-stage diabetic nephropathy by means of dialysis are evaluated. Hemodialysis (HD) was applied to 24 patients, continuous ambulatory peritoneal dialysis (OCPD) was employed in 33 patients and intermittent peritoneal dialysis (IPD) in nine patients. Cumulated experience with each technique was 529, 644, and 107 months, respectively. Ten patients were treated with a combination of two or three techniques. Hospitalization rate in patients receiving CAPD was 32 days/year, peritonitis was the most frequent condition leading to admittance (54.8%), followed by cardiovascular alterations (14.4%) and gastrointestinal complications (10.5%). On hemodialyzed patients, hospitalization rate was 24.7 days/year and complications derived from vascular access were the most frequent admittance cause (34%), followed by cardiovascular complications (20.4%) and hypertension (11.3%). Peritonitis (45%), vascular complications (15%) and metabolic impairment (15%) were the most frequent causes of admittance in IPD patients; hospitalization rate was 88 days/year. Actuarial survival in patients on CAPD was 92% during first year, 79% during second, and 64% during third and fourth years. On hemodialyzed patients, 90% of patients survived during first year and 80%, 48%, and 36% during second, third, and fourth years, respectively. On IPD, survival during first year was 63% and 12% at 18 months. By combinating two or the three methods, survival was 100% at 12 months and 88% at 4 years. Although CAPD as isolated technique may offer to diabetic patients a longer survival and HD a lower hospitalization rate, combined treatment (HD-CAPD-IPD) may provide a survival matchable to that achieved in renal transplantation.

摘要

评估了采用透析治疗终末期糖尿病肾病患者十年后的应用技术所导致的发病率和死亡率。24例患者接受血液透析(HD),33例患者采用持续性非卧床腹膜透析(CAPD),9例患者采用间歇性腹膜透析(IPD)。每种技术的累积经验分别为529、644和107个月。10例患者接受了两种或三种技术的联合治疗。接受CAPD治疗的患者住院率为每年32天,腹膜炎是导致入院的最常见情况(54.8%),其次是心血管改变(14.4%)和胃肠道并发症(10.5%)。接受血液透析的患者住院率为每年24.7天,血管通路相关并发症是最常见的入院原因(34%),其次是心血管并发症(20.4%)和高血压(11.3%)。腹膜炎(45%)、血管并发症(15%)和代谢障碍(15%)是IPD患者最常见的入院原因;住院率为每年88天。接受CAPD治疗的患者第一年的精算生存率为92%,第二年为79%,第三年和第四年为64%。接受血液透析的患者,第一年90%的患者存活,第二年、第三年和第四年分别为80%、48%和36%。接受IPD治疗的患者,第一年生存率为63%,18个月时为12%。通过联合两种或三种方法,12个月时生存率为100%,4年时为88%。尽管单独使用CAPD技术可能使糖尿病患者有更长的生存期,而HD有较低的住院率,但联合治疗(HD-CAPD-IPD)可能提供与肾移植相当的生存率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验